Overview
Navi Medical Technologies is an Australian medtech company developing paediatric technology aimed at clinical commercialization in the United States. The company is positioned in healthcare AI and medical devices, with a focus on bringing specialized technology for children into hospital settings. The company raised a Series A round reported at $7 million, with the round described as A$6.8 million, to support commercialization of its breakthrough paediatric technology in the U.S. The financing underscores investor interest in Australian healthcare innovation with global market potential.
Funding History
Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US
Frequently Asked Questions
- How much has Navi Medical Technologies raised in total?
- Navi Medical Technologies has raised a total of $7M across 1 funding round.
- What does Navi Medical Technologies do?
- Navi Medical Technologies is an Australian medtech company developing paediatric technology aimed at clinical commercialization in the United States. The company is positioned in healthcare AI and medical devices, with a focus on bringing specialized technology for children into hospital settings. The company raised a Series A round reported at $7 million, with the round described as A$6.8 million, to support commercialization of its breakthrough paediatric technology in the U.S. The financing underscores investor interest in Australian healthcare innovation with global market potential.
- Where is Navi Medical Technologies headquartered?
- Navi Medical Technologies is headquartered in Melbourne, Australia.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.